<DOC>
	<DOCNO>NCT01515748</DOCNO>
	<brief_summary>Primary Objective : - To compare progression free survival ( PFS ) two treatment arm Secondary Objectives : - Overall survival ( OS ) - Postoperative stage R0 ( complete ) resection rate - Safety : Toxicities associate neoadjuvant chemotherapy , surgery , morbidity/mortality , toxicity adjuvant chemotherapy1</brief_summary>
	<brief_title>Docetaxel+Oxaliplatin+S-1 ( DOS ) Regimen Neoadjuvant Chemotherapy Advanced Gastric Cancer</brief_title>
	<detailed_description>Patients neoadjuvant chemotherapy arm treat 3 cycle ( 1 cycle 21 day ) surgery treat year TS-1 Patients adjuvant chemotherapy arm get surgery treat year TS-1 . All patient follow study treatment death progression , whichever come first .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Tegafur</mesh_term>
	<criteria>Inclusion criterion : Patients histologically confirm , newly diagnose , localize gastric gastrooesophageal adenocarcinoma , consider resectable Patients clinical stage ( T23/N ( + ) , T4/N ( +/ ) : N positive mean ≥8 short axis ) Signed informed consent Exclusion criterion : Age &lt; 20 year ≥76 year Performance status ≥2 Eastern Cooperative Oncology Group ( ECOG ) scale The patient history malignancy within last five year except cure basal cell carcinoma skin carcinoma situ uterine cervix already successfully treat Previous surgery neoplasm stomach Patients completely recover surgery Distant metastases ( M1 ) organs include distant nodal group ( retropancreatic , paraaortic , portal , retroperitoneal , mesenteric node ) . severe/unstable angina , coronary artery bypass graft , congestive heart failure , transient ischemic attack within 6 month prior enrollment study Any previous palliative , adjuvant neoadjuvant chemotherapy and/or radiotherapy and/or immunotherapy , currently treat gastric cancer Patients active active infection sepsis Intolerance oral take malabsorption : lack physical integrity upper gastrointestinal tract malabsorption syndrome likely influence absorption TS1 . Ileus , chronic inflammatory intestinal disease extensive resection small intestine disorder limit drug resorption . This include gastric dump syndrome , indication accelerate passage small intestine indication resorption disorder intestinal surgery ≥ grade 2 severe tumour haemorrhage Simultaneous participation another study , participation another study within 4 week commencement study Pregnant lactating patient The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>